Maintenance / Service
PRODUCTS
-
Phenogel™ Organic GPC/SEC Columns
Enhance Resolution for Polymer Analysis using Non-Aqueous GPC/SEC
Phenogel™ size exclusion columns for gel permeation chromatography (GPC) are composed of highly cross-linked styrene-divinylbenzene (SDVB) and achieve high resolution and tight linear calibration curves. Phenogel™ is available in seven different pore sizes, ranging from 50 Å to 106 Å; and a linear bed configuration. Pore size distribution and pore volume are closely controlled parameters in the manufacturing process accounting for the high resolution, tight linear calibration curves, and excellent column-to-column reproducibility. USP L21 packings available.
- 5 and 10 µm particle sizes
- Narrow bore (4.6 mm ID) solvent-saver columns available
- Highly cross-linked for mechanical and chemical stability
- Temperature stable to 140 °C.
-
Modern clinical trials require modern technology. Leverage the flexibility and speed of the cloud with TrialKit electronic data capture (EDC).
-
A Transfection Solution for Gram-Scale Protein Production
The ExPERT VLx system delivers unmatched transfection scalability with MaxCyte's Flow Electroporation® technology for industry-leading reproducibility, flexibility and ease of use.
- Reduce time, cost and risk
- Transfect up to 200 billion cells, in a single-use system, in less than 30 minutes
- Obtain grams of proteins in weeks, not months
- Achieve reproducible results, superior transfection efficiency, cell viability and protein expression
- Scale seamlessly to expedite your transition from discovery to Phase 1
- Proprietary Flow Electroporation® Technology
-
The most widely trusted solution for clinical trial disclosure management
Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.
Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.
-
Seamlessly delivering your virotherapy
With industry-leading viral expertise, ReciBioPharm navigates the rapidly evolving field of virotherapy to support the development and manufacturing of your gene therapies, viral vector vaccines and oncolytic viruses (OVs).
WHITE PAPERS AND CASE STUDIES
-
Optimizing Data Services For Digital Trials With A Clinical Data Cloud
Learn how internal processes and comprehensive clinical data services for digital trials can be improved through the utilization of data clouds.
-
CDMO Accelerates Contract Manufacturing With Electronic Batch Records
A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.
-
Solving The EHR-To-EDC Challenge: A Scalable-First Approach
Unearth how industry shifts, technology adoption, and interoperability openness are paving the way for scalable solutions.
-
Powering More Efficient Clinical Development With AI And ML
Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.
-
Orthogonal Methods To Understand And Define CQAs Of AAV Therapies
An essential part of AAV vector production is the characterization of potential CQAs. Learn about novel, robust, and orthogonal methods that can be used to assess identity, purity, and residuals.
-
Life Sciences Corporation Implements eLogbooks Across 15 Sites
New regulations challenged how surgical kits were tracked and processed across 15 U.S. sites. Discover how one team balanced compliance and efficiency to keep life-saving procedures on schedule.
-
Providing Enhanced Manufacturing Data To Contracting Companies
The life sciences sector is projected to reach $220 billion by 2030. Examine the growth of CDMOs and CMOs, emphasizing the need for digitalization to meet client demands and regulatory standards.
-
CD56 Cell Depletion From PBMCs Applied To Validate A HIV-Specific ADCC Mechanism
Explore results from a study that utilized an in vivo model to assess the antibody-dependent cellular cytotoxicity (ADCC) activity of antibodies to clear HIV-infected cells.
-
Inside A Collaboration To Design Cutting Edge Modular Cleanrooms
Learn about a collaboration that has yielded advanced modular cleanrooms, integrating cutting-edge building automation, critical monitoring, and data aggregation for manufacturing intelligence.
-
Democratizes Batch Data Management For AAV Gene Therapies And Accelerates CMO Collaboration
Read the story of a leading clinical-stage biotechnology company developing gene therapy product candidates in the retinal, metabolic, and neurodegenerative therapeutic areas.
-
Four Leading Injectable Manufacturers Automate Tray Count Operations
Learn about the solutions that were developed to meet four manufacturers' constantly changing product mixes, improving manufacturing operations by reducing risk, improving compliance, and more.
-
Contamination In The Shadows: Risks Lurking From Environmental Issues
Discover how science-based bio-decontamination strategies effectively eliminate invisible pathogens and rapidly restore facilities to operational safety following major infrastructure disruptions.
NEWS
-
Infovista Enables Accurate 5G RedCap Network Planning For Operators' New IoT Services5/23/2024
Infovista today announced support for 5G RedCap network planning with the launch of the latest version of its AI-powered RF planning solution, Infovista Planet.
-
GovSignals Extends AI-Powered Workflow Solution To Government Agencies With Multi-Million Dollar DIU Contract Win, Advances FedRAMP & IL5 Readiness3/18/2025
GovSignals, the first AI platform to automate the full process of finding and bidding on government contracts, announced today its expansion from supporting government contractors to directly serving government agencies.
-
Quark Embeds AI To Convert Unstructured Into Structured Content In Newest Release Of Quark Publishing Platform NextGen4/17/2024
Quark Software, the global provider of content automation, intelligence and design software, today announced the newest release of Quark Publishing Platform (QPP) NextGen, its cloud-based content automation platform that simplifies the complexities associated with the entire enterprise content lifecycle management process, from creation to consumption, in a fully integrated CCMS.